Investors | Kisaco Research

Investors

Obesity and Metabolic Innovation Forum
4 December, 2024
Boston, MA

Why Should Investors Attend?

Download the agenda to discover the key opportunities and insights into the evolving obesity and metabolic treatment landscape, unlocking pathways for impactful and strategic investments.

DOWNLOAD AGENDA

  • Understand market dynamics and identify investment opportunities in a sector projected to reach $100 billion by 2034. 
  • Gain knowledge about the latest breakthroughs, including GLP-1 drug combinations, gene therapies, and digital therapeutics shaping the future of obesity treatment. 
  • Connect with leaders from biotech, pharma, and health tech to explore strategic partnerships and co-investment possibilities. 
  • Learn about the regulatory landscape and reimbursement strategies that impact market access and investment timelines. 
  • Hear from providers and payers on adopting new treatments, aligning investment decisions with real-world needs and outcomes. 

Top sessions for you

Panel – Market Access Landscape and Strategies for Cost Containment

What investors seek in Obesity Innovation

The Future of GLP-1 Drugs – A Panacea for Chronic Disease?

Companies in our Community